Vol. 25 No. 3 (2021)
ACQUIRED HEART DISEASES

Five-year outcomes of the modified Ross surgery in adults: experience from one center

I.I. Chernov
Federal Center for Cardiovascular Surgery, Astrakhan
S.T. Enginoev
Federal Center for Cardiovascular Surgery, Astrakhan; Astrakhan State Medical University, Astrakhan
Bio
D.A. Kondratyev
Federal Center for Cardiovascular Surgery, Astrakhan
D.Yu. Kozmin
Federal Center for Cardiovascular Surgery, Astrakhan
V.V. Demetskaya
Federal Center for Cardiovascular Surgery, Astrakhan
E.R. Aliev
Astrakhan State Medical University, Astrakhan
D.G. Tarasov
Federal Center for Cardiovascular Surgery, Astrakhan

Published 2021-09-28

Keywords

  • acquired heart disease,
  • aortic regurgitation,
  • Ross operation

How to Cite

Chernov, I., Enginoev, S., Kondratyev, D., Kozmin, D., Demetskaya, V., Aliev, E., & Tarasov, D. (2021). Five-year outcomes of the modified Ross surgery in adults: experience from one center. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 25(3), 43–50. https://doi.org/10.21688/1681-3472-2021-3-43-50

Abstract

Background. The Ross operation was first proposed in 1967 by D. Ross, and numerous studies have shown that it has excellent long-term results. However, in some patients, it can lead to late dilatation of the pulmonary autograft, which in turn can contribute to repeat operations. To avoid this complication, technical modifications of the Ross operation have been proposed.
Aim. To evaluate the immediate and five-year outcomes of the modified Ross surgery in adults.
Methods. This retrospective study included patients aged 18 years and older with aortic valve lesions who underwent a modified Ross procedure by one surgeon between January 2014 and December 2019. The median follow-up period was 23 (12–68) months.
Results. The study included 43 adult patients. The average age of the patients was 40.0 ± 11.7 years, and 33 (76.7%) were men. The main cause of aortic valve dysfunction was severe aortic regurgitation (32 patients, 74.4%). Infective endocarditis was diagnosed as a cause of aortic valve pathology in 13 (30.2%) patients. Bicuspid aortic valve was present in 29 cases (67.4%). In two cases (4.7%), mini-sternotomy (‘T-shape’) was performed. Ten (23.2%) patients underwent combined interventions. The median duration of cardiopulmonary bypass was 143 (129–160) minutes, and duration of aortic cross-clamp was 116 (109–131) minutes. The autologous inclusion technique was used in 22 (51.2%) cases and the Dacron inclusion technique in 21 (48.8%) cases. Outcomes included no in-hospital mortality, acute renal failure requiring haemodialysis in three patients (7%), pacemaker implantation in two (4.7%), resternotomy for bleeding and stroke in one patient (2.3%) and perioperative myocardial injury in two (4.7%). The five-year overall survival, freedom from reoperation and freedom from dilatation of the ascending aorta or pulmonary autograft ≥ 5 cm after the modified Ross operation were 97.4%, 100.0% and 100.0%, respectively.
Conclusion. Modified Ross surgery in adults has excellent immediate outcomes with no in-hospital mortality. The five-year overall survival, freedom from reoperation and freedom from aortic dilatation or pulmonary autograft were 97.4%, 100.0% and 100.0%, respectively.

Received 15 February 2021. Revised 3 June 2021. Accepted 4 June 2021.

Funding: The study did not have sponsorship.

Conflict of interest: The authors declare no conflicts of interests.

Contribution of the authors
Conception and study design: I.I. Chernov, S.T. Enginoev, D.A. Kondratyev, D.Yu. Kozmin
Data collection and analysis: E.R. Aliev, V.V. Demetskaya, D.A. Kondratyev, D.Yu. Kozmin
Statistical analysis: S.T. Enginoev
Drafting the article: I.I. Chernov, S.T. Enginoev
Critical revision of the article: I.I. Chernov, D.G. Tarasov
Final approval of the version to be published: I.I. Chernov, S.T. Enginoev, D.A. Kondratyev, D.Yu. Kozmin, V.V. Demetskaya, E.R. Aliev, D.G. Tarasov

References

  1. Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., Lumg B., Lancellotti P., Lansac E., Muñoz D.R., Rosenhek R., Sjögren J., Mas P.T., Vahanian A., Walther T., Wendler O., Windecker S., Zamorano J.L., ESC Scientific Document Group. 2017 ESC / EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791. PMID: 28886619. https://doi.org/10.1093/eurheartj/ehx391
  2. Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P. 3rd, Gentile F., Jneid H., Krieger E.V., Mack M., McLeod C., O'Gara P.T., Rigolin V.H., Sundt T.M. 3rd, Thompson A., Toly C. 2020 ACC / AHA Guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology / American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. PMID: 33332149. https://doi.org/10.1161/cir.0000000000000923
  3. Ross D.N. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet. 1967;2(7523):956-958. PMID: 4167516. https://doi.org/10.1016/s0140-6736(67)90794-5
  4. El-Hamamsy I., Eryigit Z., Stevens L.-M., Sarang Z., George R., Clark L., Melina G., Takkenberg J.J.M., Yacoub M.H. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet. 2010;376(9740):524-531. PMID: 20684981. https://doi.org/10.1016/S0140-6736(10)60828-8
  5. David T.E., David C., Woo A., Manlhiot C. The Ross procedure: outcomes at 20 years. J Thorac Cardiovasc Surg. 2014;147(1):85-93. PMID: 24084276. https://doi.org/10.1016/j.jtcvs.2013.08.007
  6. Martin E., Mohammadi S., Jacques F., Kalavrouziotis D., Voisine P., Doyle D., Perron J. Clinical outcomes following the Ross procedure in adults: A 25-year longitudinal study. J Am Coll Cardiol. 2017;70(15):1890-1899. PMID: 28982503. https://doi.org/10.1016/j.jacc.2017.08.030
  7. Mastrobuoni S., de Kerchove L., Solari S., Astarci P., Poncelet A., Noirhomme P., Rubay J., El Khoury G. The Ross procedure in young adults: over 20 years of experience in our Institution. Eur J Cardiothorac Surg. 2016;49(2):507-513. PMID: 25736279. https://doi.org/10.1093/ejcts/ezv053
  8. Poh C.L., Buratto E., Larobina M., Wynne R., O’Keefe M., Goldblatt J., Tatoulis J., Skillington P.D. The Ross procedure in adults presenting with bicuspid aortic valve and pure aortic regurgitation: 85 % freedom from reoperation at 20 years. Eur J Cardiothorac Surg. 2018;54(3):420-426. PMID: 29546380. https://doi.org/10.1093/ejcts/ezy073
  9. Brown J.W., Ruzmetov M., Rodefeld M.D., Mahomed Y., Turrentine M.W. Incidence of and risk factors for pulmonary autograft dilation after Ross aortic valve replacement. Ann Thorac Surg. 2007;83(5):1781-1789. PMID: 17462399. https://doi.org/10.1016/j.athoracsur.2006.12.066
  10. Kouchoukos N.T., Masetti P., Nickerson N.J., Castner C.F., Shannon W.D., Dávila-Román V.G. The Ross procedure: long-term clinical and echocardiographic follow-up. Ann Thorac Surg. 2004;78(3):773-781. PMID: 15336990. https://doi.org/10.1016/j.athoracsur.2004.02.033
  11. Elkins R.C., Lane M.M., McCue C., Chandrasekaran K. Ross operation and aneurysm or dilation of the ascending aorta. Semin Thorac Cardiovasc Surg. 1999;11(4 Suppl 1):50-54. PMID: 10660166.
  12. Simon-Kupilik N., Bialy J., Moidl R., Kasimir M.-T., Mittlböck M., Seebacher G., Wolner E., Simon P. Dilatation of the autograft root after the Ross operation. Eur J Cardiothorac Surg. 2002;21(3):470-473. PMID: 11888765. https://doi.org/10.1016/S1010-7940(02)00016-7
  13. Luciani G.B., Mazzucco A. Aortic root disease after the Ross procedure. Curr Opin Cardiol. 2006;21(6):555-560. PMID: 17053403. https://doi.org/10.1097/01.hco.0000245742.93453.1d
  14. David T.E., Omran A., Ivanov J., Armstrong S., de Sa M.P., Sonnenberg B., Webb G. Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg. 2000;119(2):210-220. PMID: 10649195. https://doi.org/10.1016/S0022-5223(00)70175-9
  15. Skillington P.D., Mokhles M.M., Takkenberg J.J.M., Larobina M., O’Keefe M., Wynne R., Tatoulis J. The Ross procedure using autologous support of the pulmonary autograft: techniques and late results. J Thorac Cardiovasc Surg. 2015;149(2 Suppl):S46-S52. PMID: 25439787. https://doi.org/10.1016/j.jtcvs.2014.08.068
  16. David T.E. Aortic valve replacement with pulmonary autograft: subcoronary and aortic root inclusion techniques. Oper Tech Thorac Cardiovasc Surg. 2012;17(1):27-40. https://doi.org/10.1053/j.optechstcvs.2011.09.002
  17. Carrel T., Kadner A. Long-term clinical and imaging follow-up after reinforced pulmonary autograft Ross procedure. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2016;19(1):59-62. PMID: 27060045. https://doi.org/10.1053/j.pcsu.2015.11.005
  18. Slater M., Shen I., Welke K., Komanapalli C., Ungerleider R. Modification to the Ross procedure to prevent autograft dilatation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;8(1):181-184. PMID: 15818376. https://doi.org/10.1053/j.pcsu.2005.01.022
  19. Чернов И.И., Козьмин Д.Ю., Макеев С.А., Демецкая В.В., Тарасов Д.Г. Непосредственные результаты модифицированной операции Росса. Патология кровообращения и кардиохирургия. 2016;20(1):12-18. [Chernov I.I., Kozmin D.Yu., Makeev S.A., Demetskaya V.V., Tarasov D.G. Immediate results of modified Ross procedure. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2016;20(1):12-18. (In Russ.)]
  20. Al Rashidi F., Bhat M., Höglund P., Meurling C., Roijer A., Koul B. The modified Ross operation using a Dacron prosthetic vascular jacket does prevent pulmonary autograft dilatation at 4.5-year follow-up. Eur J Cardiothorac Surg. 2010;37(4):928-933. PMID: 20018521. https://doi.org/10.1016/j.ejcts.2009.11.008
  21. Zoghbi W.A., Adams D., Bonow R.O., Enriquez-Sarano M., Foster E., Grayburn P.A., Hahn R.T., Han Y., Hung J., Lang R.M., Little S.H., Shah D.J., Shernan S., Thavendiranathan P., Thomas J.D., Weissman N.J. Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303-371. PMID: 28314623. https://doi.org/10.1016/j.echo.2017.01.007
  22. Baumgartner H., Hung J., Bermejo J., Chambers J.B., Edvardsen T., Goldstein S., Lancellotti P., LeFevre M., Miller F. Jr., Otto C.M. Recommendations on the echocardiographic assessment of aortic valve stenosis: A focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):372-392. PMID: 28385280. https://doi.org/10.1016/j.echo.2017.02.009
  23. Караськов А.М., Богачев-Прокофьев А.В., Шарифулин Р.М., Демин И.И., Железнев С.И., Опен А.Б., Пивкин А.Н. Результаты процедуры Росса у пациентов с сопутствующей аневризмой восходящего отдела аорты. Ангиология и сосудистая хирургия. 2016;22(1):142-149. [Karaskov A.M., Bogachev-Prokofiev A.V., Sharifulin R.M., Demin I.I., Zheleznev S.I., Open A.B., Pivkin A.N. Outcomes of the Ross procedure in patients with an accompanying ascending aortic aneurysm. Angiology and Vascular Surgery. 2016;22(1):150-158. (In Russ.)]